Reporting quality of randomized-controlled trials in multiple sclerosis from 2000 to 2015, based on CONSORT statement
详细信息 查看全文
- 作者：Dimitrios Rikosa ; Efthimios Dardiotisa ; Georgios Tsivgoulisb ; c ; Elias Zintzarasd ; e ; Georgios M. Hadjigeorgioua ; gmhadji@med.uth.gr" class="auth_mail" title="E-mail the corresponding author
- 关键词：RCT ; randomized controlled trial ; CONSORT ; Consolidated Standards of Reporting Trials ; MS ; multiple sclerosis ; RRMS ; Relapsing Remitting MS ; SPMS ; Secondary Progressive MS ; PPMS ; Primary Progressive MS ; CIS ; Clinically Isolated Syndrome
- 刊名：Multiple Sclerosis and Related Disorders
- 出版年：2016
- 出版时间：September 2016
- 年：2016
- 卷：9
- 期：Complete
- 页码：135-139
- 全文大小：458 K
文摘
- m" id="list_li0005">
- •
Reporting of more than 75% of CONSORT items, in RCTs regarding MS, was increased during the three five-year time periods from 2000 to 2015 (p<0.05).
- •
Critical (approval) RCTs had a better CONSORT compliance than the rest articles.
- •
Higher impact factor journals publish RCTs with higher CONSORT compliance.
- •
Reporting of RCTs regarding MS is not yet optimal.
- •
Further improving the quality of RCTs and their reporting could assist health care providers to their clinical decisions, increase the clinical significance of RCTs, and direct more specifically future medical research.